For the quarter ending 2026-03-31, TVRD has $25,817K in assets. $11,312K in debts. $19,851K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 19,851 | 20,734 | 21,418 | 20,648 |
| Short-term investments | 5,130 | 10,077 | 15,042 | 20,346 |
| Prepaid expenses and other current assets | 345 | 727 | 1,983 | 2,136 |
| Total current assets | 25,326 | 31,538 | 38,443 | 43,130 |
| Property and equipment, net | 44 | 52 | 60 | 68 |
| Intangible assets, net | 306 | 322 | 338 | 354 |
| Operating lease right-of-use assets | 124 | 144 | 163 | 181 |
| Other non-current assets | 17 | 17 | 17 | 17 |
| Total assets | 25,817 | 32,073 | 39,021 | 43,750 |
| Accounts payable | 4,620 | 3,219 | 4,078 | 2,425 |
| Accrued expenses | 6,518 | 7,707 | 6,849 | 8,144 |
| Operating lease liabilities, current portion | 120 | 116 | 113 | 109 |
| Total current liabilities | 11,258 | 11,042 | 11,040 | 10,678 |
| Operating lease liabilities, net of current portion | 54 | 85 | 115 | 145 |
| Total liabilities | 11,312 | 11,127 | 11,155 | 10,823 |
| Common stock, 0.001 par value 150,000,000 shares authorized as of march 31, 2026 and december 31, 2025 9,381,344 shares issued and outstanding as of march 31, 2026 and december 31, 2025 | 9 | 9 | 9 | 9 |
| Additional paid-in capital | 131,749 | 131,379 | 131,025 | 130,579 |
| Accumulated other comprehensive income | 1 | 8 | 7 | -13 |
| Accumulated deficit | -117,254 | -110,450 | -103,175 | -97,648 |
| Total stockholders' equity | 14,505 | 20,946 | 27,866 | 32,927 |
| Total liabilities and stockholders' equity | 25,817 | 32,073 | 39,021 | 43,750 |
Tvardi Therapeutics, Inc. (TVRD)
Tvardi Therapeutics, Inc. (TVRD)